Occuity (@occuity) 's Twitter Profile
Occuity

@occuity

Developing #optical #medtech screening & monitoring devices for some of humanity's greatest health challenges - #diabetes #myopia #glaucoma #alzheimers #pm1

ID: 1321766577990152193

linkhttps://www.occuity.com calendar_today29-10-2020 10:52:35

1,1K Tweet

3,3K Followers

3,3K Following

Occuity (@occuity) 's Twitter Profile Photo

Tomorrow, we find out if we were successful in the Hard Tech Investment of the Year category at the UKBAA Angel Investment Awards 2023! 🎉 A huge thank you to our incredible angel investors! 💡 #UKBAAAwards #Innovation #Healthcare #MedTech #Oculomics #AngelInvestors #Occuity

Tomorrow, we find out if we were successful in the Hard Tech Investment of the Year category at the UKBAA Angel Investment Awards 2023! 🎉

A huge thank you to our incredible angel investors! 💡

#UKBAAAwards #Innovation #Healthcare #MedTech #Oculomics #AngelInvestors #Occuity
Occuity (@occuity) 's Twitter Profile Photo

Exciting news! Our Senior Research Scientist, Dr. Alistair Bounds, was invited to write a feature for Physics World on oculomics. This highlights our work and the growing recognition of oculomics in health diagnostics. #HealthTech #Oculomics zurl.co/yJEI

Exciting news! Our Senior Research Scientist, Dr. Alistair Bounds, was invited to write a feature for <a href="/PhysicsWorld/">Physics World</a> on oculomics. This highlights our work and the growing recognition of oculomics in health diagnostics. #HealthTech #Oculomics
zurl.co/yJEI
Occuity (@occuity) 's Twitter Profile Photo

Thrilled to announce that Jamie Serjeant has won the RAEng Engineers Trust Young Engineer of the Year award! 🏆 Jamie’s groundbreaking work in optical diagnostics is revolutionising healthcare. Congrats, Jamie! 🌟 #EngineeringExcellence #RAEngAwards zurl.co/5Pk0

Occuity (@occuity) 's Twitter Profile Photo

We're delighted to announce that Occuity has received a Notice of Intent to Grant for 3 new patents! 🎉 These innovations will further our mission to revolutionise optical diagnostics for chronic conditions.👁️💡 #MedTech #Innovation #HealthTech zurl.co/LhUU

We're delighted to announce that Occuity has received a Notice of Intent to Grant for 3 new patents! 🎉 These innovations will further our mission to revolutionise optical diagnostics for chronic conditions.👁️💡 #MedTech #Innovation #HealthTech 

zurl.co/LhUU
Occuity (@occuity) 's Twitter Profile Photo

Responding to the recent BBC article on Alzheimer's treatments like Lecanemab, we explore the importance of early detection. Discover how we're innovating diagnosis in our latest blog. 🧠🔍 ]#Alzheimers #HealthcareInnovation #EarlyDetection zurl.co/K8r1

Responding to the recent BBC article on Alzheimer's treatments like Lecanemab, we explore the importance of early detection. Discover how we're innovating diagnosis in our latest blog. 🧠🔍 ]#Alzheimers #HealthcareInnovation #EarlyDetection zurl.co/K8r1
Occuity (@occuity) 's Twitter Profile Photo

Discover why optical biometry is the gold standard in myopia management. Accurate, non-invasive, and essential for better eye health outcomes. Learn more in our latest blog post! 👁️👉 zurl.co/Y1sg #Myopia #EyeHealth #OpticalBiometry

Discover why optical biometry is the gold standard in myopia management. Accurate, non-invasive, and essential for better eye health outcomes. Learn more in our latest blog post! 👁️👉 zurl.co/Y1sg #Myopia #EyeHealth #OpticalBiometry
Occuity (@occuity) 's Twitter Profile Photo

Productive days at #ESCRS2024 showcasing our PM1 and AX1! Hosted 25 meetings in 3 days with global distributors. Loved our visit to the Sagrada Familia too! Read more about our journey here: zurl.co/BZAG #ESCRS2024 #Ophthalmology

Productive days at #ESCRS2024 showcasing our PM1 and AX1! Hosted 25 meetings in 3 days with global distributors. Loved our visit to the Sagrada Familia too! 

Read more about our journey here: zurl.co/BZAG 

#ESCRS2024 #Ophthalmology
Occuity (@occuity) 's Twitter Profile Photo

🏆 We’re honoured to have won National Medtech & Healthtech StartUp of the Year at the UK StartUp Awards! Our work in Oculomics continues to gain momentum as we transform healthcare diagnostics. Exciting times ahead! #Medtech #UKSA2024 #Oculomics 🔗 zurl.co/i4yD

🏆 We’re honoured to have won National Medtech &amp; Healthtech StartUp of the Year at the UK StartUp Awards! Our work in Oculomics continues to gain momentum as we transform healthcare diagnostics. Exciting times ahead! #Medtech  #UKSA2024 #Oculomics 🔗 zurl.co/i4yD
Occuity (@occuity) 's Twitter Profile Photo

🚀 Exciting news! Occuity signs with Skymed Ltd. as the exclusive distributor for PM1 Pachymeter in Israel. Skymed's Tzah Kimchi says: "The PM1 is a remarkable device that will benefit glaucoma, refractive surgery clinics & more." zurl.co/AdWH #MedTech #Ophthalmology

🚀 Exciting news! Occuity signs with Skymed Ltd. as the exclusive distributor for PM1 Pachymeter in Israel. Skymed's Tzah Kimchi says: "The PM1 is a remarkable device that will benefit glaucoma, refractive surgery clinics &amp; more."

zurl.co/AdWH 
#MedTech #Ophthalmology
Occuity (@occuity) 's Twitter Profile Photo

🚀 BREAKING NEWS! Our PM1 Pachymeter just received CE Marking! This non-contact, handheld device is set to transform glaucoma screening. 🌍 Learn more about our journey to bring safer, faster eye care solutions to the world! 👉 zurl.co/6NQQ #Glaucoma #optometry

🚀 BREAKING NEWS! Our PM1 Pachymeter just received CE Marking! This non-contact, handheld device is set to transform glaucoma screening. 🌍 Learn more about our journey to bring safer, faster eye care solutions to the world! 👉 zurl.co/6NQQ  #Glaucoma #optometry
Occuity (@occuity) 's Twitter Profile Photo

In this video, Optometrist Jason Higginbotham introduces the PM1 Pachymeter – the first handheld, non-contact optical pachymeter. He covers setup, CCT measurement, and shares pro tips for effective use. #Optometry #PM1Pachymeter #EyeCare #glaucoma zurl.co/hY6O

Occuity (@occuity) 's Twitter Profile Photo

🌟 We lit up Occuity for Diwali! Celebrating the Festival of Lights with our diverse team, delicious food, and vibrant decor brought us closer and filled the office with joy. 🎉 Read more in our latest blog! #Diwali #TeamOccuity #WorkplaceCulture zurl.co/ZPsw

Occuity (@occuity) 's Twitter Profile Photo

Exciting news! Occuity partners with Von Hoff as the exclusive distributor for the PM1 #Pachymeter in Switzerland & Liechtenstein. CE certified, the PM1 revolutionises glaucoma care. 👉 Read more here zurl.co/bg9VF #Ophthalmology #PM1 #Glaucoma #refractivesurgery

Exciting news! Occuity partners with Von Hoff as the exclusive distributor for the PM1 #Pachymeter in Switzerland &amp; Liechtenstein. CE certified, the PM1 revolutionises glaucoma care. 👉 Read more here zurl.co/bg9VF 

#Ophthalmology #PM1 #Glaucoma #refractivesurgery
Occuity (@occuity) 's Twitter Profile Photo

Occuity is closing it's current investment round tomorrow - Friday, 20th December 2024. If you wish to take advantage of investing in this round before it closes, please visit zurl.co/3CMR5 . #investment #EIS #EQUITY #MEDTECH #MYOPIA

Occuity is closing it's current investment round tomorrow - Friday, 20th December 2024. If you wish to take advantage of investing in this round before it closes, please visit  zurl.co/3CMR5 .

#investment #EIS #EQUITY #MEDTECH #MYOPIA
Occuity (@occuity) 's Twitter Profile Photo

We’re excited to partner with Abioz Technologies as our exclusive distributor in France! 🇫🇷 Together, we’ll expand access to non-invasive optical technologies across Europe. 🌍 Read more here: zurl.co/OQWnk #Occuity #Partnership #gluacoma #myopia #PM1 #AX1 #France

We’re excited to partner with Abioz Technologies as our exclusive distributor in France! 🇫🇷 Together, we’ll expand access to non-invasive optical technologies across Europe. 🌍 

Read more here: zurl.co/OQWnk

#Occuity #Partnership #gluacoma #myopia #PM1 #AX1 #France
Occuity (@occuity) 's Twitter Profile Photo

💡 China has reclassified Red Light Therapy for myopia, meaning existing treatments are no longer approved. But what does this mean for RLRL therapy? 🌍 📖 Read the full article here: zurl.co/Hh6hA 💬 If you're an ECP - What do you think? #myopia #optometry #RLRL

💡 China has reclassified Red Light Therapy for myopia, meaning existing treatments are no longer approved. But what does this mean for RLRL therapy? 🌍

📖 Read the full article here: zurl.co/Hh6hA 

💬 If you're an ECP - What do you think? 

#myopia #optometry #RLRL
Occuity (@occuity) 's Twitter Profile Photo

💬 How much does myopia management cost in the UK & Ireland? We're building a clearer picture. If you offer myopia treatments, take 2 minutes to share your pricing insight. #myopiamanagement #costs #survey #optometry #myopiacontrol zurl.co/4OEXQ

💬 How much does myopia management cost in the UK &amp; Ireland? We're building a clearer picture. If you offer myopia treatments, take 2 minutes to share your pricing insight.

#myopiamanagement #costs #survey #optometry #myopiacontrol

zurl.co/4OEXQ
Occuity (@occuity) 's Twitter Profile Photo

We're proud to share that Occuity has been recognised as part of a landmark £6 billion UK-India trade announcement, highlighting our recent collaboration with leading Indian medtech company Remidio. zurl.co/JPLmv #UKIndia #Medtech #Healthcare #Myopia #AX1 #PM1

We're proud to share that Occuity has been recognised as part of a landmark £6 billion UK-India trade announcement, highlighting our recent collaboration with leading Indian medtech company Remidio.

zurl.co/JPLmv 

#UKIndia #Medtech #Healthcare #Myopia #AX1 #PM1